Association between Baseline Osteoarthritic Features on MR Imaging and Clinical Outcome after Genicular Artery Embolization for Knee Osteoarthritis.


Journal

Journal of vascular and interventional radiology : JVIR
ISSN: 1535-7732
Titre abrégé: J Vasc Interv Radiol
Pays: United States
ID NLM: 9203369

Informations de publication

Date de publication:
04 2021
Historique:
received: 11 09 2020
revised: 04 12 2020
accepted: 07 12 2020
pubmed: 3 2 2021
medline: 6 7 2021
entrez: 2 2 2021
Statut: ppublish

Résumé

To explore the association between baseline osteoarthritis (OA)-related magnetic resonance (MR) imaging features and pain reduction after genicular artery embolization (GAE) in patients with mild-to-moderate symptomatic knee OA resistant to conservative therapy. This was a retrospective analysis of patients with mild-to-moderate symptomatic knee OA treated with GAE using imipenem-cilastatin sodium. The clinical outcome was scored at baseline and 6 months after treatment using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). MR images were scored using the MR imaging osteoarthritis knee score. Linear regression was used to evaluate associations of before-treatment MR imaging scores with WOMAC Fifty-four patients (22.2% male; median age, 69.4 years; median WOMAC In patients with mild-to-moderate symptomatic knee OA treated with GAE, the presence and severity of full-thickness cartilage defects, effusion synovitis, bone marrow lesions, osteophytes, and cartilage surface area scores at baseline are associated with less favorable clinical outcomes at 6 months.

Identifiants

pubmed: 33526342
pii: S1051-0443(20)31033-2
doi: 10.1016/j.jvir.2020.12.008
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

497-503

Informations de copyright

Copyright © 2020 SIR. Published by Elsevier Inc. All rights reserved.

Auteurs

Tijmen A van Zadelhoff (TA)

Department of Radiology and Nuclear Medicine, Erasmus University Medical Center Rotterdam, P.O. box 2040, 3000 CA Rotterdam, the Netherlands.

Yuji Okuno (Y)

Musculoskeletal Intervention Center, Okuno Clinic, Tokyo, Japan.

Pieter K Bos (PK)

Department Othopaedic Surgery, Erasmus University Medical Center Rotterdam, P.O. box 2040, 3000 CA Rotterdam, the Netherlands.

Sita M A Bierma-Zeinstra (SMA)

Department Othopaedic Surgery, Erasmus University Medical Center Rotterdam, P.O. box 2040, 3000 CA Rotterdam, the Netherlands; Department of General Practice, Erasmus University Medical Center Rotterdam, P.O. box 2040, 3000 CA Rotterdam, the Netherlands.

Gabriel P Krestin (GP)

Department of Radiology and Nuclear Medicine, Erasmus University Medical Center Rotterdam, P.O. box 2040, 3000 CA Rotterdam, the Netherlands.

Adriaan Moelker (A)

Department of Radiology and Nuclear Medicine, Erasmus University Medical Center Rotterdam, P.O. box 2040, 3000 CA Rotterdam, the Netherlands.

Edwin H G Oei (EHG)

Department of Radiology and Nuclear Medicine, Erasmus University Medical Center Rotterdam, P.O. box 2040, 3000 CA Rotterdam, the Netherlands. Electronic address: e.oei@erasmusmc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH